Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces New Joint Venture with LeafLink Inc.

Cannabis-focused investment and operating platform Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF), alongside LeafLink Inc., this morning announced the establishment of LeafLink Services International ULC, a new venture focused on licensing and leveraging LeafLink’s dominant business-to-business marketplace and supply chain technology platform for deployment through regulated international cannabis markets. “We have been very impressed with LeafLink’s deep market penetration and their understanding of cannabis companies’ needs and behaviors,” Narbé Alexandrian, president of Canopy Rivers, stated in the news release. “The number of brands and products within our new cannabis economy has been explosive, making it difficult for retailers to deal with multiple parties in an increasingly fragmented market. As regulated cannabis consumption and distribution proliferates around the world, LeafLink International will introduce the industry’s leading SaaS-enabled marketplace to the global stage to create a new standard for expediting the cannabis supply chain in regulated markets.”

To view the full press release, visit http://ibn.fm/Pj34r

About Canopy Rivers

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth (TSX: WEED) (NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Canopy Rivers Inc. RIV, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) to Present at Seventh Annual ARM Cell & Gene Therapy Investor Day in New York City

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced that it will be presenting at the upcoming ARM Cell & Gene Therapy Investor Day, hosted by the Alliance for Regenerative Medicine, to be held in New York City on March 21, 2019. Unique to the medical and biotech communities, the investor conference focuses on fast-paced, concise presentations from more than 35 companies, consolidated to a one-day conference while allowing opportunities for one-on-one partnering with venture and strategic investors. Genprex’s presentation is scheduled for Thursday, March 21, at 2:30-2:45 p.m. EDT in the Main Bar Room of the Metropolitan Club, One East 60th Street, New York, NY 10022. “I’m looking forward to attending Cell & Gene Therapy Investor Day for the first time, with the opportunity to share information about Genprex’s mission and our gene therapy technologies,” Genprex President and COO Julien Pham, MD, MPH said in the news release. “With a wide array of companies and industry leaders all presenting in a single day, this conference enables us and the investment community to take the pulse of where the industry is heading. It is an incredible honor to be a part of this event.”

To view the full press release, visit http://ibn.fm/BhatA

About Genprex, Inc.

Genprex, Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Genprex Inc. GNPX, MissionIRNewsBreaks | Leave a comment

Earth Science Tech Inc. (ETST) Employs Consultant in Preparation for Proposed Dual Listing

  • Earth Science Tech has engaged Derek Lindsay as a consultant to ensure compliance as it pursues dual listing on the Canadian Securities Exchange
  • Lindsay’s areas of expertise include raising capital, strategically advising companies, cultivating investor relations and managing risk
  • Cross-listing to attract new investors and capital to the company

Earth Science Tech Inc. (OTCQB: ETST), an innovative biotechnology company operating in the fields of hemp cannabinoids, nutraceuticals, pharmaceuticals, medical devices and research and development, recently announced its employment of Derek Lindsay as a consultant in its pursuance of a potential dual listing of the company’s common shares on the Canadian Securities Exchange (CSE). This will be an addition to its current OTCQB listing.

Lindsay, who has helped both private and public companies in accelerating their growth, offers a diverse array of expertise areas. His knowledge (http://ibn.fm/vnSnM) includes “capital raising, strategic advice, investor relations, and risk management.” He discussed a dual listing’s ability to bring Earth Science Tech new investors and capital.

“Considering that ETST’s [research and development] division is based in Canada, cross-listing appears well-aligned with the corporate vision,” Lindsay said in a news release (http://ibn.fm/dmMAf). “Once this milestone is complete, ongoing efforts will be needed to monitor and ensure compliance, build shareholder value, and communicate with investors. I look forward to supporting the Company in these endeavors.”

Nickolas Tabraue, Earth Science Tech’s president and chairman, spoke to the effectiveness of Lindsay’s employment. “We believe Derek’s expertise makes him the perfect fit to ensure that we improve communication with our shareholders and progress on the CSE listing,” he noted. “I plan on sharing further updates as we advance this initiative.”

Earth Science Tech boasts a strong in-house team of industry experts in the fields of nutraceuticals, dietary supplements, and life sciences. Diversified, with a foothold in multiple markets, the company is passionate about making strategic partnerships and pursuing subsidiary acquisitions with the goal of becoming a world leader in the CBD sector. One such subsidiary, Canna Inno Laboratories Inc., is based out of Montreal, Canada, and provides Earth Science Tech with access to government grants. The company’s first grant has been already approved, strengthening its market presence in Canada’s recreational cannabis and CBD product industry.

For more information, visit the company’s website at www.EarthScienceTech.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Earth Science Tech, Inc. ETST | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Aims to Conduct Further Human Clinical Trials Following Positive TurboCBD Results

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) plans to conduct additional clinical trials using DehydraTECH(TM) in CBD after recently reporting noteworthy results of cardiovascular performance improvements with TurboCBD. A recent article discussing the company reads, “TurboCBD is Lexaria’s proprietary DehydraTECH-powered, CBD-fortified hemp-oil capsule. The capsules are formulated with full-spectrum hemp oil, ginseng and ginkgo for enhanced focus and memory. They are marketed as a mental and physical boost aimed at helping to remove brain fog, fatigue and stress. TurboCBD is molecularly engineered for quick and high absorption rates into the circulatory system. . . . In a recent press release (http://ibn.fm/OwOtT), Lexaria announced that the results from a healthy-human clinical trial provided evidence that a single 90mg dose of TurboCBD resulted in lower blood pressure, higher blood flow to the brain, faster delivery onset of CBD into the bloodstream and larger quantities of CBD within the blood as compared to an equal dose of generic CBD. Due to the positive results of this study, the company plans to conduct additional human clinical trials over the course of the next year using DehydraTECH in CBD.”

To view the full article, visit http://ibn.fm/1EGED

About Lexaria Bioscience Corp.

Lexaria Bioscience has developed and outlicenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and quicker onset of lipophilic active molecules. Lexaria has 10 patents granted in the United States and Australia, and has filed over 50 patent applications worldwide across 10 patent families. Lexaria’s technology provides more rapid delivery to the bloodstream, as well as important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Lexaria Bioscience Corp. (LXRP), MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Supporting the Advancement of Cannabis Industry Entrepreneurs

Cannabis Strategic Ventures (OTC: NUGS) cultivates and partners with brands internationally to develop leaders in the cannabis and CBD marketplace. The company recently added to its staffing capabilities through the acquisition of Worldwide Staffing Group. An article discussing the company reads, “Primarily, the company is focused on supporting the growth of entrepreneurs in this industry. It has made strategic acquisitions, in turn offering outsourced personnel solutions informed by the latest growth trends in the cannabis market. Cannabis Strategic Ventures supports all members of the cannabis market, including cultivators, manufacturers and dispensaries. The company offers mentorship and other important services to young and existing cannabis brands seeking to find staying power in the industry. . . . Most notably, Worldwide Staffing Group, a separate wholly owned subsidiary, works within Cannabis Strategic Ventures to provide noncannabis-related employment and staffing services. The latter company aims to continue growing its business operations further in the cannabis staffing area, especially focusing on the California markets, where adult recreational cannabis use has been legalized.”

To view the full article, visit http://ibn.fm/cBWBq

About Cannabis Strategic Ventures Inc.

Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over-the-Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Cannabis Strategic Ventures Inc. NUGS, MissionIRNewsBreaks | Leave a comment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Innovating on Numerous Fronts with DehydraTECH Drug Delivery Platform

  • Lexaria Bioscience is focusing on its unique technology for the delivery of bioactive compounds
  • The company’s concentration on oral ingestion results in an option that often healthier than other delivery methods
  • Its DehydraTECH technology has potential applications for nicotine absorption

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) focuses on technology for the improved delivery of bioactive compounds. Its DehydraTECH drug delivery platform fosters healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules. The company’s process changes the way edible cannabinoids enter the body (http://ibn.fm/CB41E). A drug delivery innovator, Lexaria Bioscience is headquartered in Kelowna, British Columbia.

Lexaria’s technology has been shown to be effective in numerous global studies, significantly assisting rapidity and quantity of absorption for a range of lipophilic (fat-soluble), bioactive molecules. In essence, the company disrupts the manner in which cannabinoids enter the bloodstream through the gastrointestinal tract (http://ibn.fm/CsUCz). Lexaria’s emphasis on oral ingestion provides a practical and often healthier option to other delivery methods for bioactive substances used extensively today. This includes inhalational delivery via smoking.

The DehydraTECH platform masks taste, lessens the time of onset and increases bio-absorption by 5-10 times. The technology is patent protected for cannabidiol and all other non-psychoactive cannabinoids. Lexaria has patents pending for THC, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine, other psychoactive cannabinoids and other molecules. These patents apply to manifold consumer/pharma product dosage forms and include food liquid emulsions, capsules, tablets and more.

The Lexaria Hemp Co. holds exclusive international rights to the Lexaria patent portfolio related to hemp-based applications. Moreover, its Canadian subsidiary, Lexaria CanPharm Corp., owns exclusive international rights to Lexaria’s intellectual property that’s applicable to psychotropic bioactive molecules, which act upon human CB1 and CB2 receptors in those global geographic areas where it is permissible to do so (http://ibn.fm/d2roZ).

Lexaria Bioscience’s business model involves developing and out-licensing its DehydraTECH platform to third-party partners/distributors (http://ibn.fm/Bx1uI). In addition, its business model involves the sale of Lexaria-developed and joint venture products. The company’s product sales include hemp oil-based CBD (cannabidiol) offerings. Its TurboCBD hemp oil capsules contain ginseng and ginkgo to promote better focus and memory and have been evaluated in clinical tests.

Lexaria’s product sales additionally include ViPova-branded premium teas. These teas deliver cannabidiol in a number of flavors and have been available for several years, showcasing Lexaria’s leadership position in beverage formulations.

Lexaria Bioscience has a collaborative research agreement with Canada’s National Research Council. This research agreement is to investigate opportunities associated with bioavailability enhancement of lipophilic active ingredient compositions (http://ibn.fm/UP5RO).

Lexaria Bioscience has engaged in research regarding the use of its technology for nicotine absorption, relating to the nicotine industry. It has partnered, via wholly owned subsidiary Lexaria Nicotine LLC, with one of the world’s largest tobacco companies to drive innovation in oral, reduced risk nicotine consumer products using the patented DehydraTECH drug delivery platform (http://ibn.fm/IHDmy). Lexaria Nicotine aims to perform a wide-ranging series of clinical investigations of oral forms of nicotine delivery, funded by its partner, employing Lexaria’s patented DehydraTECH technology.

Lexaria Bioscience continues its R&D for the improved delivery of bioactive compounds. The company offers investors the potential to earn ROI from its disruptive technology in the emerging market of low cost edibles. Lexaria continues to advance its technology that enables consumer benefits and the lowest cost-per-serving.

For more information, visit the company’s website at www.LexariaBioscience.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Lexaria Bioscience Corp. (LXRP) | Leave a comment

Earth Science Tech Inc. (ETST) Seeks Dual Listing; Boasts Increased Product Lines, Distribution

  • Pursuing dual listing of common shares on the Canadian Securities Exchange
  • Engaged a full-service law firm and consultant to manage compliance
  • Lots of opportunity in 2019 with increased product lines, increased distribution and new partnerships

Earth Science Tech Inc. (OTCQB: ETST), an innovative biotech company based in Florida, is actively pursuing a dual listing of its common shares on the Canadian Securities Exchange (“CSE”). In December 2018, ETST engaged the counsel of Fasken, a full-service law firm with offices in Canada and worldwide, to assist with the process, including preparing and filing the required documentation (http://ibn.fm/Ui1o2).

In addition, ETST has engaged consultant Derek Lindsay to manage compliance while the company moves toward dual listing (http://ibn.fm/yTlbe). Along with managing compliance, Lindsay will be tasked with implementing an investor relations program and improving communications with investors.

“Dual listing is a major achievement and one that can provide ETST access to new investors and capital,” Lindsay, who has solid experience in accelerating the growth of both private and public companies, stated in a news release. Lindsay has served in various capacities and is well-versed in capital raising, strategic advising, investor relations and risk management.

Actively working toward dual listing is not halting the company’s continued work in the CBD, nutraceutical and pharmaceutical fields; nor is it slowing its advancement of medical devices or research and development activities. Preparations are in place for the launch of three new CBD products. The first commercial batch of Hygee medical devices is nearing completion and will be launched in Vietnam, which will act as a proving ground for the introduction of the device into other countries (http://ibn.fm/bAg6i).

Already distributing products to 40 countries, ETST recently expanded its sales reach into Mexico and South America through a distribution partnership agreement with Forzagen (http://ibn.fm/57cke). In addition to global distribution expansion, the company is increasing its markets in the United States. Thanks to a recent agreement with CannaBiz and Desert Sun Distribution, ETST’s CBD product line will soon be available to chiropractors, dispensaries, pharmacies, health care practitioners, athletic clubs and clinics.

In a news release (http://ibn.fm/B91JM), ETST Chairman Nickolas S. Tabraue said, “We have a lot of opportunity on deck for 2019, and we look forward to sharing the results of our strategies, which include our Latin American distribution partnership and upcoming High Grade Full Spectrum Iq2 Cannabinoids shot.”

For more information, visit the company’s website at www.EarthScienceTech.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Earth Science Tech, Inc. ETST | Leave a comment

Cannabis Strategic Ventures Inc. (NUGS) Utilizes Diversified Brand Portfolio to Provide High-Quality Products and Staffing Services to Cannabis Industry

  • Cannabis industry job postings rose 445 percent in 2017
  • Cannabis Strategic Ventures poised to meet this growing demand through multiple diverse subsidiaries
  • PureOrganix, one such subsidiary, offers top-quality products that meet strict health and safety specifications

Cannabis Strategic Ventures Inc. (OTC: NUGS), a company focused on supporting entrepreneurial growth in the legal cannabis sector, offers personnel solutions to equip cannabis industry purveyors with the staffing resources that they need to achieve continued growth. Serving all vertical layers of the cannabis industry, Cannabis Strategic Ventures customizes its staffing services to each company’s individual needs, servicing cultivators, manufacturers, dispensaries and others in the cannabis marketplace.

The company aims to garner a corner of the $10 billion cannabis and $900 million hemp industries. In its approach, Cannabis Strategic Ventures has cultivated a diverse brand portfolio to broaden its industry reach.

One of its major subsidiaries, Pure Applied Sciences Inc., has cultivated a rich portfolio of ultra-high quality products. Its main brand is PureOrganix, a line of organic and pure cannabis oils and related accessories. The brand is responsible for noteworthy products like a “redefined” vape pen made from environmentally friendly materials, which features 400 percent more battery power than similar offerings from competitors. All PureOrganix products, also including batteries and apparel, conform to the most stringent current good manufacturing practices (“cGMP”) and meet FDA guidelines for active pharmaceuticals ingredients (“API”), an achievement that most small companies find extremely difficult to attain.

Additionally, another of the company’s subsidiaries, BudHire, is an outsourced employment service which uses a proven recruiting formula to help clients find the strongest candidates for positions within the cannabis industry. Through BudHire, Cannabis Strategic offers a variety of services to professionals, including temporary, seasonal and permanent staffing solutions, as well as human resources consulting.

Subsidiary Worldwide Staffing Group operates within the company as an independent wholly owned subsidiary. Its purpose is to provide non-cannabis-related employment and staffing services. As Worldwide continues to develop its operations into more vertical sectors of the cannabis industry, Cannabis Strategic plans to utilize the subsidiary’s aptitude and experience to move further into the cannabis staffing arena, focusing specifically on California’s markets.

As the cannabis industry continues to thrive, Cannabis Strategic has seen a dramatic increase in companies’ need for increased outsourced staffing. Specifically, cannabis industry job postings increased by 445 percent in 2017, a shocking increase from the prior year-over-year growth of 18 percent in 2016. The company feels well-positioned to meet this staffing demand through its diversified brands and strong industry presence.

For more information, visit the company’s website at www.CannabisStrategic.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Cannabis Strategic Ventures Inc. NUGS | Leave a comment

Youngevity International Inc. (NASDAQ: YGYI) Building CBD-Infused Coffee Products for Wellness Market

  • An estimated 64 percent of American adults report drinking coffee on a regular basis, with the majority preparing coffee at home
  • Youngevity International is focused on field-to-cup distribution in the coffee market through wholly owned subsidiary CLR Roasters
  • Youngevity and CLR Roasters announced on March 6 that they plan to introduce two cannabidiol-infused coffee brands in May
  • CBD-infused beverages are becoming a popular new market space, with the potential for between $900 million and $4.4 billion in revenues by 2024

Youngevity International Inc. (NASDAQ: YGYI) is cultivating a market that appeals to the more than 100 million Americans who drink coffee, as well as consumers in the burgeoning cannabis industries, thanks largely to a breakthrough in its efforts to infuse coffee with consistent dosing of hemp-derived cannabidiol (CBD) for wellness lifestyle interests.

Youngevity announced plans to launch two brands of cannabidiol-infused coffees on March 6, stating that sales are expected to begin in May. The HempFX brand is expected to roll out as a direct sales product through YGYI’s large sales network early in the month, followed by full-scale distribution by the end of the month. The company’s CLR Roasters subsidiary also anticipates a late-May rollout of its Javalution brand for retail store shelf distribution, and it has already begun retail sales presentations (http://ibn.fm/uq7ih).

“We have been perplexed in delivering CBD to a cup of coffee at consistent doses, but now we have a solution that passes the scrutiny of laboratory testing and we are excited to bring these products to market. Our team at Khrysos has cracked the code on the production of water-soluble CBDs,” Youngevity President and CFO Dave Briskie stated in a news release about the project.

Khrysos Global is a Florida-based manufacturer of hemp-based CBD extraction equipment that was acquired by Youngevity in February (http://ibn.fm/3pDY4). The deal included ownership of INX Labs and its testing facilities, which Briskie hailed as “a cornerstone” of the company’s developing CBD market strategy.

Both brands will be available in four profiles – Donut Shop, Dark Roast, House Blend and French Vanilla – according to the announcement. They will all come in a single-serve format that provides 10 milligrams of CBD per cup, and, since the company’s water-soluble CBD technology is deliverable in both powders and liquids, YGYI has a wide range for potential product development.

Youngevity is an omni-direct lifestyle company that gathers a virtual Main Street of products and services under one corporate entity with a hybrid direct sales business model that values e-commerce and social selling. Wholly owned subsidiary CLR Roasters produces gourmet coffees under its own boutique brands and manufactures a variety of private labels for major national chains, as well as Youngevity’s direct sales channel. The company remains one of North America’s largest suppliers to the cruise line industry.

CLR Roasters recently began filling a five-year contract to process and ship its first containers of green coffee, primarily comprised of high grown, washed Nicaraguan conventional coffees, as well as some naturals (http://ibn.fm/NaPPF). The company is also in the process of constructing one of Central America’s largest processing mills to expand its coffee plantation and processing operation in Nicaragua (http://ibn.fm/WWNWN) and increase its participation with its Nicaraguan-based partners from 50 percent to 75 percent of profits in the green coffee distribution business. The facility, when complete, is expected to house 28,000 square feet of office space and a 160,000-square-foot warehouse capable of holding 48 million pounds of green coffee with the ability to process over 53 million pounds of green coffee on an annual basis.

An estimated 64 percent of American adults drink coffee on a regular basis, according to a 2018 study with a sample of about 3,000 respondents commissioned by the National Coffee Association (“NCA”) (http://ibn.fm/TYemO). About 79 percent of those who reported drinking coffee said that they made it at home. Coffee is just the latest beverage market entry to anticipate CBD infusion, following on the heels of alcoholic drinks and sodas. Analysts at Deloitte foresee the potential revenues for the cannabis-infused beverages market at somewhere between $900 million and $4.4 billion by 2024, depending on the percentage of the cannabis products market that infusion captures (http://ibn.fm/HOT1X).

For more information, visit the company’s website at www.YGYI.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Youngevity International Inc. YGYI | Leave a comment

MissionIRNewsBreaks – The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) Partners with Valens Groworks to Accelerate Canadian Hemp Strategy

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced its entry into a multi-year extraction services contract with Valens GroWorks Corp. (CSE: VGW) (OTCQB: VGWCF), a licensed provider of cannabis products and services specializing in various proprietary extraction, distillation, cannabinoid isolation and purification technologies. According to the update, the partnership with Valens will accelerate TGOD’s Canadian hemp strategy, allowing for early market entry of its organic hemp-derived CBD products in the coming months. “We are excited to work with TGOD, Canada’s premier certified organic producer,” Valens CEO Tyler Robson said in the news release. “Organic resonates with consumers, and Valens looks forward to helping accelerate TGOD’s time to market with the launch of its hemp-derived CBD product line in the coming months.”

To view the full press release, visit http://ibn.fm/mTcgn

About the Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, The Green Organic Dutchman Holdings Ltd. TGODF | Leave a comment